Copart has resumed opportunistic share buybacks, deploying $500 million, reflecting disciplined capital allocation and a rational approach to shareholder returns. CPRT’s core moat remains intact; the ...

KLA benefits from semiconductor process-control demand and rising services revenue but trades at steep premiums—see why KLAC stock may be overvalued now.

Summary In 2009, the S&P 500 closed below 700 for the first time since 1996; this year, it’s trading not far below 7,000, or roughly ten times higher. Since that Monday close, the S&P 500 has rallied ...

Korch reported a reduction in full-year guidance: "We now expect net income attributable to Vail Resorts in the range of $144 million to $190 million and resort reported EBITDA in the range of $745 ...

RGA Investment Advisors discusses AI integration and new stakes in Celsius Holdings and Lattice Semiconductor. Read the full ...

CEO David Fischel described 2025 as a year of “tremendous progress,” emphasizing technological and commercial advancements despite ongoing challenges. Fischel highlighted the company’s mission to ...

Good afternoon, and welcome to the Vail Resorts Fiscal Second Quarter 2026 Earnings Conference Call. Today's conference is being recorded. [Operator Instructions] I will now turn the call over to ...

Fidelity Growth Company Fund gained 4.82% in Q4 2025, outperforming its benchmark through strong tech selection. Read the ...

Crude oil futures plunged post-market after CBS News reported that President Trump said the U.S.-Israeli war with Iran was "very far ahead of schedule" and "very complete, pretty much." ...

In pipeline progress, Celiprolol for VEDS enrolled 8 patients in Q4, bringing the total to 52 out of a planned 150 in the Phase III DISCOVER study. McFarlane noted engagement with the FDA for ...

BlackRock, Inc. faces reputational and market risks after limiting withdrawals from its $26B private credit fund. Learn more about BLK stock here.

The RiverPark Long/Short Opportunity Fund returned 0.13% in Q4 2025, with Alphabet and Eli Lilly as top contributors. Read ...